Abstract
Objective: To investigate whether there is a linear association between the degree of prematurity and the risk for long-term ophthalmic morbidity among preterm infants. Study design: A population-based, retrospective cohort study, which included all singleton deliveries occurring between 1991 and 2014 at a single tertiary medical center. All infants were divided into four groups according to gestational age categories: extremely preterm births, very preterm births, moderate to late preterm births and term deliveries (reference group). Hospitalizations of offspring up to 18 years of age involving ophthalmic morbidity were evaluated. Survival curves compared cumulative hospitalizations and regression models controlled for confounding variables. Results: During the study period, 243,363 deliveries met the inclusion criteria. Ophthalmic-related hospitalization rates were lower among children born at term (0.9%) as compared with extremely preterm (3.6%), very preterm (2%), and moderate to late preterm (1.4%) born offspring (p < 0.01; using the chi-square test for trends). The survival curve demonstrated significantly different hospitalization rates between the gestational ages (p < 0.001). The regression demonstrated an independent risk for ophthalmic morbidity among extremely preterm born offspring (adjusted hazard ratio 3.8, confidence interval 1.6–9.2, p < 0.01), as well as very preterm and moderate to late preterm (adjusted hazard ratio 2.2 and 1.5, respectively) as compared with term deliveries. Conclusions: The risk for long-term ophthalmic-related hospitalization of preterm offspring gradually decreases as the gestational age increases.
Keywords: ophthalmic morbidities, retinopathy of prematurity, gestational age, preterm delivery
1. Introduction
The consequences of prematurity are well established in literature, causing long-term and potentially severe effects on pediatric and infantile morbidity and mortality [1,2]. With incomplete maturation, preterm infants are at a greater risk for developing a wide spectrum of medical complications, including hypothermia, jaundice, respiratory disorders [3], immunologic problems [4], neurodevelopmental problems [5,6,7], increased susceptibility to infections, hypoglycemia and feeding problems. In accordance with preterm newborns’ shorter intrauterine periods, ocular development in preterm infants is also subject to a number of abnormal influences, given the reduced time for proper growth and support in a unique environment [8]. Previous literature demonstrated that children who were born very preterm (28–32 weeks) are at a significantly higher risk for abnormal visual and neurological development, when compared to children born at full term [9]. These abnormalities include retinopathy of prematurity (ROP), strabismus, color vision deficits, visual field defects, decreased visual acuity and refractive error [10].
The World Health Organization (WHO) subcategorizes preterm births based on gestational age: extremely preterm (less than 28 weeks delivery), very preterm (28 to 32 weeks delivery), moderate to late preterm (32 to 37 weeks delivery) [11].
A recent study showed that long-term ophthalmic morbidities of offspring is significantly associated with early term delivery [12]. Early preterm-born offspring were found to have an independent risk for long-term ophthalmic morbidity (adjusted hazard ratio 2.51, confidence interval 1.91–3.29) as compared with full term offspring. In our study, we sought to investigate one step further to understand the relative risk for long-term ophthalmic morbidity between the different subcategories of preterm deliveries.
2. Materials and Methods
A retrospective cohort study of all singleton pregnancies in women who gave birth between the years 1991 and 2014 was conducted. Data was taken from the Soroka Univer-sity Medical Center (SUMC), the major tertiary hospital in the Negev region of Israel and the largest birth center in the country. The Negev region has continued to see increasing immigration since the 1990s. Therefore, the present study was based on non-selective population data. The study protocol was a received informed consent exemption by the SUMC institutional review board and was exempt from informed consent. The study population included two different ethnic groups: Jewish and Bedouins, who differ in their economic status, levels of education, and traditional beliefs [13]. However, prenatal care services are available to all Israeli citizens free of charge (covered by universal national health Insurance) [13]. Nevertheless, prenatal care services utilization is lower in Bedouin women as compared to Jewish women for a variety of social, cultural, and geographical access issues [14,15].
The primary exposure was defined as pre-term delivery (before 37 weeks). The control groups consisted of newborns born at later gestations. Gestational age was based on the best obstetric estimate determined by providers and used for clinical decision making. The standard criteria used involved consideration of the clinical history and earliest ultrasound scan. If the last menstrual period (LMP) was certain and consistent with the ultrasound, dating was based on the LMP. If the ultrasound was not consistent with the LMP, or the LMP was unknown, ultrasound data were used to determine gestational age.
Excluded from the study were fetuses with congenital malformations or chromosomal abnormalities, as well as perinatal mortality cases (intrauterine fetal death, intra-partum death, and post-partum death) and nonsingleton births. All offspring were divided into four groups according to their gestational age at delivery: extremely preterm birth: 24–28 gestational weeks, very preterm birth: 28–32 gestational weeks, moderate to late preterm birth: 32–37 gestational weeks and term deliveries: above 37 weeks.
The long-term outcomes assessed included all hospitalizations of offspring at SUMC until the age of 18 years that involved ophthalmic morbidity. The term “ophthalmic morbidity” included four categories: visual disturbances, retinopathy of prematurity, ocular infection and hospitalization. All diagnoses during hospitalization were predefined according to a set of ICD-9 procedures and diagnostic codes, detailed in Table A1.
Follow-up was terminated once any of the following occurred: after the first hospitalization, due to any of the predefined ophthalmic morbidities, any hospitalization resulting in death of the child, or when the child reached 18 years of age (calculated by date of birth).
Data was collected from two databases that were cross-linked and merged: the computerized hospitalization database of SUMC (“Demog-ICD9”), and the computerized perinatal database of the Obstetrics and Gynecology Department. The perinatal database consists of information recorded immediately following an obstetrician delivery. Experienced medical secretaries routinely reviewed the information prior to entering it into the database to ensure maximal completeness and accuracy. Coding was carried out after assessing medical prenatal care records, as well as routine hospital documents.
The SPSS package 23rd ed. (IBM/SPSS, Chicago, IL, USA) was used for statistical analysis. Categorical data is shown in counts and rates. Associations between the gestational age categories, background and outcome characteristics were assessed using the chi-square and ANOVA tests. In order to demonstrate the cumulative hospitalization incidences over time among the study groups, a Kaplan–Meier survival curve was used, and the log-rank test was used to assess the difference between the curves.
For the purposes of establishing an independent association between specific gestational age and the future incidence of ophthalmic-related hospitalizations of the offspring, a Cox regression model was constructed. The model was adjusted for confounding and clinically significant variables, including maternal age and diabetes (pre-gestational and gestational). All analyses were two-sided, and a p-value of ≤0.05 was statistically considered.
3. Results
A total of 243,363 deliveries were included in the study; 405 were between 24–28 gestational weeks (0.2%), 1084 deliveries were between 28–32 weeks (0.4%), 14,956 deliveries were between 32–37 weeks (6.1%) and 226,918 occurred at ≥37 gestational weeks (93.2%).
Table 1 summarizes maternal characteristics by delivery week category. Maternal age was similar in all delivery groups, with an overall average of 28.08 ± 6.3. Diabetes was more likely to occur in deliveries between 32–37 weeks (7.5%). Hypertensive disorders were more common in deliveries between 28–32 weeks (17.7%).
Table 1.
Maternal characteristics according to gestational age.
| Maternal Characteristic | Extremely Preterm: 24–28 Weeks (n = 405) | Very Preterm: 28–32 Weeks (n = 1084) | Moderate to Late Preterm: 32–37 Weeks (n = 14,956) | Term Deliveries: more than 37 weeks (n = 22,6918) | p-Value |
|---|---|---|---|---|---|
| Ethnicity, n (%) | <0.01 | ||||
| Jewish | 190 (46.9%) | 463 (42.7%) | 6883 (46%) | 107,673 (47.5%) | |
| Bedouin | 215 (53.1%) | 621 (57.3%) | 8073 (54%) | 119,245 (52.5%) | |
| Maternal age, years, mean ± SD | 28.44 ± 6.5 | 28.16 ± 6.3 | 28.14 ± 6.2 | 28.16 ± 5.7 | <0.01 |
| Diabetes 1, n (%) | 5 (1.2%) | 57 (5.3%) | 1118 (7.5%) | 10,973 (4.8%) | <0.01 |
| Hypertensive disease 2, n (%) | 40 (9.9%) | 192 (17.7%) | 1839 (12.3%) | 10,169 (4.5%) | <0.01 |
1 Including pre gestational and gestational diabetes; 2 Including pre gestational, gestational hypertension and pre- eclampsia.
Table 2 summarizes pregnancy outcomes of all four groups. Mean birth weight was positively associated to gestational age; ranging from 855.1 ± 429.5 for 24–28 weeks of age to 3264 ± 446.6 among the mature group, while small for gestational age (SGA) as well as low birth weight (LBW( were most common in the former group (13.3% and 97.5% respectively). Cesarean deliveries were significantly more common among women in 28–32 weeks of gestation (44.8%, p-value < 0.01).
Table 2.
Pregnancy outcomes for children (age < 18) by delivery week.
| Pregnancy Outcome | Extremely Preterm: 24–28 Weeks (n = 405) | Very Preterm: 28–32 Weeks (n = 1084) | Moderate to Late Preterm: 32–37 Weeks (n = 14,676) | Term Deliveries: more than 37 Weeks (n = 226,917) | p-Value |
|---|---|---|---|---|---|
| Birthweight, gr mean ± SD | 855.1 ± 429.5 | 1560.7 ± 623.4 | 2532.4 ± 506.3 | 3264.2 ± 446.6 | <0.01 |
| Small for gestational age 1, n (%) | 54 (13.3%) | 54 (5%) | 607 (4.1%) | 10,547 (4.6%) | <0.01 |
| Low birth weight 2, n (%) | 395 (97.5%) | 992 (91.5%) | 7030 (47%) | 7805 (3.4%) | <0.01 |
| Cesarean delivery, n (%) | 139 (34.3%) | 486 (44.8%) | 4444 (29.7%) | 27,908 (12.3%) | <0.01 |
1 Small for gestational age (SGA) < 5th percentile for gestational age; 2 Low birth weight (LBW) < 2500 g.
The long-term ophthalmological morbidities based on hospitalizations is presented in Table 3. Rates of visual disturbances and retinopathy of prematurity (ROP) were significantly higher among the 24–28 gestational weeks group (0.7%, p-value < 0.01; 1.4%, p-value < 0.01 respectively), while ocular infection was highest among newborns in the 28–32 weeks of gestation (0.9%, p-value < 0.01). Total ophthalmic hospitalization rates were highest among the 24–28 gestational weeks group (3.6%, p-value < 0.01 using the chi-square test for trends), and gradually decreased with increasing gestational week (2% among 28–32 weeks, 1.4% among 32–37 weeks, and 0.9% among 37+ weeks). A decrease in the number of hospitalizations with gestational age was also documented while stratifying for ethnicity. Offspring born between 24–28 weeks had the highest cumulative incidence of hospitalizations (Figure 1) due to ophthalmological morbidity, followed by offspring born at 28-36 and those born at ≥37 gestational weeks (p < 0.001).
Table 3.
Selected long-term ophthalmological morbidities for children (age < 18) by delivery week.
| Ophthalmological Morbidity |
Extremely Preterm: 24–28 Weeks (n = 138) | Very Preterm: 28–32 Weeks (n = 891) | Moderate to Late Preterm: 32–37 Weeks (n = 14,676) | Term Deliveries: more than 37 Weeks (n = 226,482) | p-Value | |
|---|---|---|---|---|---|---|
| Visual disturbances, n (%) | 1 (0.7%) | 0 (0%) | 36 (0.2%) | 245 (0.1%) | <0.01 | |
| ROP, n (%) | 2 (1.4%) | 2 (0.2%) | 0 (0%) | 0 (0%) | <0.01 | |
| Ocular Infections, n (%) | 1 (0.7%) | 8 (0.9%) | 123 (0.8%) | 1336 (0.6%) | 0.02 | |
| Total ophthalmic Hospitalization, n (%) | Bedouin | 2 (1.4%) | 12 (1.3%) | 123 (0.8%) | 1190 (0.5%) | <0.01 |
| Jewish | 3 (2.2%) | 6 (0.7%) | 85 (0.6%) | 907 (0.4%) | <0.01 | |
| All | 5 (3.6%) | 18 (2%) | 208 (1.4%) | 2097 (0.9%) | <0.01 |
Figure 1.
Kaplan-Meier survival curve demonstrating the cumulative incidence of. ophthalmological-related hospitalizations compared to delivery time in weeks.
In the multivariate Cox regression model for offspring long-term risk of ophthalmic-related hospitalizations (Table 4), earlier deliveries were associated with higher risk for hospitalization, compared to the most mature group (24–28) weeks: HR = 3.8; CI95% 2.6–9.2; 28–32 weeks: HR = 2.2; CI95% 1.4–3.5; 32–37 weeks: HR = 1.5; CI95% 1.3–1.7).
Table 4.
Cox regression analysis of the association between week of birth and ophthalmic-related hospitalization of children (age < 18).
| Hazard Ratio | 95% CI | p-Value | |
|---|---|---|---|
| Extremely preterm: 24–28 weeks | 3.8 | 1.6–9.2 | <0.01 |
| Very preterm: 28–32 weeks | 2.2 | 1.4–3.5 | <0.01 |
| Moderate to late preterm: 32–37 weeks | 1.5 | 1.3–1.7 | <0.01 |
| Term deliveries: more than 37 weeks | 1 (Reference) | ||
| Mother age at birth | 0.9 | 0.98–0.99 | 0.02 |
| Diabetes | 1.0 | 0.8–1.2 | 0.6 |
4. Discussion
This large population-based cohort study demonstrates an increased risk for childhood and adolescence long-term ophthalmic morbidities as the gestational age becomes earlier among the pre-term deliveries. The risk remained significantly elevated among all the preterm groups while controlling for relevant maternal factors.
Numerous studies have identified an association between early gestational age at birth and the risk of poor health outcomes, based on incidence of morbidities, mortality and hospitalization rates [16,17]. A growing body of evidence has also shown ophthalmic morbidity among preterm infants. Kozeis et al. [18] found preterm infants to be associated with impairment of some aspects of visual function.
Although the pathophysiology is still not fully understood, complex multifactorial mechanisms have been suggested as the potential causes for ocular damage from preterm delivery. The suggested mechanisms include deficiencies in both innate and adaptive immunity [19], hypoxic-ischemic induced inflammation and cytokine injury, reperfusion injury, toxin-mediated injury, infection [20,21], and insufficient endogenous hormones (e.g., Cortisol & thyroxin), often exhibited as transient hypothyroxinemia of prematurity (THOP) [22].
Vast epidemiological studies conducted worldwide on ROP showed that despite geographical variability, the incidence of ROP was similar [14,15,16,17,18]. A study conducted by the Australian and New Zealand Neonatal Network (ANZNN) showed that the incidence of severe ROP was higher (34%) in infants born before 25 weeks gestation when compared to infants born at 25–26 weeks gestation (12.9%) [23]. Similar results have been found in North America, the UK and Indonesia [24,25,26].
Our findings revealed that the highest rate of ROP was observed in infants born at 24–28 weeks gestation (1.4%), with a declining rate for more advanced gestational age and reaching zero cases in those born after 32 weeks’ gestation. These results are consistent with previous studies examining the rate of ROP [27,28,29,30] and are likely to be explained by the fact that ROP is a disease of developing blood vessels, which are still considered underdeveloped at the beginning of the third trimester [31].
Additional long-term ophthalmological morbidities, such as visual disturbances, were examined in our study and showed the same pattern. The higher visual disturbances in preterm babies are a consequence of the higher retinopathy rate and other reasons e.g., osteopenia of prematurity [32]. Other types of vision disturbances include sub-categories, such as strabismus (both exotropia and esotropia), refractive errors, visual field deficits, color vision errors, astigmatism, cortical blindness and more. A recent study comparing strabismus in premature and term children found that the risk for strabismus in premature children was substantially higher than in full-term children (16.2% vs. 3.2%) [33]. Other ophthalmological morbidities related to prematurity, such as ROP, were linked to increased risk for strabismus as well [34].
Many factors contribute to the increased susceptibility of preterm infants to infections. Prematurity is associated with underdeveloped ocular surface defense mechanisms and has also been associated with neonatal conjunctivitis [35]. While previous studies showed an increase in the risk for general ocular infection among preterm newborns compared to term newborns [36], our analysis did not show a conclusive trend. Infants born between 24–28 weeks of gestation showed a lower proportion of ocular infections compared to those born during weeks 28–32 (0.7% compared to 0.9% respectively). This result could be explained by the smaller size of the preterm group and requires further analysis.
The key strength of our study was the use of a large cohort in a single medical center providing broad follow-up of children up to 18 years of age. This allowed for the investigation of substantially larger numbers of infants to be followed-up on than could be achieved by individual NICU follow-up studies, and simplified the monitoring of all infants for the purposes of comparison.
A major limitation of our study is its retrospective nature, as such studies may only suggest an association rather than causation. An additional limitation is the fact that information on other important risk factors, such as lifestyle, nutrition, perinatal treatment and other family factors was not available in the datasets. Two more challenges stemmed from the choice of ophthalmic-related hospitalizations as the present study’s endpoint: (1) Most of the ophthalmic morbidity is probably catered to in an outpatient setting (as discussed earlier). However, all significant ocular morbidity is routed to the SUMC, as it is the only tertiary hospital in the South of Israel (2) Offspring born earlier are more likely to be hospitalized in general, and therefore may be more frequently diagnosed with ophthalmic morbidities.
5. Conclusions
Our study was able to find a significant association between degree of prematurity and long-term ocular morbidities up to 18 years of age. A markedly increasing risk of severe adverse neonatal outcomes was observed as gestational age decreased. Further studies could raise awareness for early interventions, improve children’s health outcomes and decrease the burden on health care systems attributed to these diseases.
Appendix A
Table A1.
Supplement Data—Ophthalmic Diagnoses.
| Group | Subgroup | Code | Diagnosis Description |
|---|---|---|---|
| Ophthalmic | Infectious inflammatory | 370 | KERATITIS |
| 3643 | UNSPECIFIED IRIDOCYCLITIS | ||
| 3708 | OTHER FORMS OF KERATITIS | ||
| 3709 | UNSPECIFIED KERATITIS | ||
| 3720 | ACUTE CONJUNCTIVITIS | ||
| 3723 | OTHER AND UNSPECIFIED CONJUNCTIVITIS | ||
| 3729 | UNSPECIFIED DISORDER OF CONJUNCTIVA | ||
| 3732 | CHALAZION | ||
| 3736 | PARASITIC INFESTATION OF EYELID | ||
| 3739 | UNSPECIFIED INFLAMMATION OF EYELID | ||
| 36000 | PURULENT ENDOPHTHALMITIS, UNSPECIFIED | ||
| 36011 | SYMPATHETIC UVEITIS | ||
| 36012 | PANUVEITIS | ||
| 36019 | OTHER ENDOPHTHALMITIS | ||
| 36212 | EXUDATIVE RETINOPATHY | ||
| 36320 | CHORIORETINITIS, UNSPECIFIED | ||
| 36322 | HARADA’S DISEASE | ||
| 36403 | SECONDARY IRIDOCYCLITIS, INFECTIOUS | ||
| 36404 | SECONDARY IRIDOCYCLITIS, NONINFECTIOUS | ||
| 36410 | CHRONIC IRIDOCYCLITIS, UNSPECIFIED | ||
| 36424 | VOGT-KOYANAGI SYNDROME | ||
| 37021 | PUNCTATE KERATITIS | ||
| 37031 | PHLYCTENULAR KERATOCONJUNCTIVITIS | ||
| 37040 | KERATOCONJUNCTIVITIS, UNSPECIFIED | ||
| 37049 | OTHER KERATOCONJUNCTIVITIS | ||
| 37055 | CORNEAL ABSCESS | ||
| 37059 | OTHER INTERSTITIAL AND DEEP KERATITIS | ||
| 37200 | ACUTE CONJUNCTIVITIS, UNSPECIFIED | ||
| 37202 | ACUTE FOLLICULAR CONJUNCTIVITIS | ||
| 37203 | OTHER MUCOPURULENT CONJUNCTIVITIS | ||
| 37205 | ACUTE ATOPIC CONJUNCTIVITIS | ||
| 37211 | SIMPLE CHRONIC CONJUNCTIVITIS | ||
| 37213 | VERNAL CONJUNCTIVITIS | ||
| 37214 | OTHER CHRONIC ALLERGIC CONJUNCTIVITIS | ||
| 37220 | BLEPHAROCONJUNCTIVITIS, UNSPECIFIED | ||
| 37230 | CONJUNCTIVITIS, UNSPECIFIED | ||
| 37240 | PTERYGIUM, UNSPECIFIED | ||
| 37261 | GRANULOMA OF CONJUNCTIVA | ||
| 37300 | BLEPHARITIS, UNSPECIFIED | ||
| 37311 | HORDEOLUM EXTERNUM | ||
| 37312 | HORDEOLUM INTERNUM | ||
| 37313 | ABSCESS OF EYELID | ||
| 37400 | ENTROPION, UNSPECIFIED | ||
| 37405 | TRICHIASIS OF EYELID WITHOUT ENTROPION | ||
| 37500 | DACRYOADENITIS, UNSPECIFIED | ||
| 37502 | CHRONIC DACRYOADENITIS | ||
| 37530 | DACRYOCYSTITIS, UNSPECIFIED | ||
| 37532 | ACUTE DACRYOCYSTITIS | ||
| 37541 | CHRONIC CANALICULITIS | ||
| 37542 | CHRONIC DACRYOCYSTITIS | ||
| 37543 | LACRIMAL MUCOCELE | ||
| 37600 | ACUTE INFLAMMATION OF ORBIT, UNSPECIFIED | ||
| 37601 | ORBITAL CELLULITIS | ||
| 37610 | CHRONIC INFLAMMATION OF ORBIT, UNSPECIFIED | ||
| 37611 | ORBITAL GRANULOMA | ||
| 37612 | ORBITAL MYOSITIS | ||
| 37613 | PARASITIC INFESTATION OF ORBIT | ||
| 37730 | OPTIC NEURITIS, UNSPECIFIED | ||
| 37731 | OPTIC PAPILLITIS | ||
| 37732 | RETROBULBAR NEURITIS (ACUTE) | ||
| 37739 | OTHER OPTIC NEURITIS | ||
| 37900 | SCLERITIS, UNSPECIFIED | ||
| 37909 | OTHER SCLERITIS | ||
| 376010 | PERIORBITAL CELLULITIS | ||
| Retinopathy of prematurity | 36220 | RETINOPATHY OF PREMATURITY, UNSPECIFIED | |
| 36221 | RETROLENTAL FIBROPLASIA | ||
| 36223 | RETINOPATHY OF PREMATURITY, STAGE 1 | ||
| 362211 | RETINOPATHY OF PREMATURITY | ||
| Visual disturbances | 3670 | HYPERMETROPIA | |
| 3671 | MYOPIA | ||
| 3672 | ASTIGMATISM | ||
| 3682 | DIPLOPIA | ||
| 3688 | OTHER SPECIFIED VISUAL DISTURBANCES | ||
| 3689 | UNSPECIFIED VISUAL DISTURBANCE | ||
| 3698 | UNQUALIFIED VISUAL LOSS, ONE EYE | ||
| 3699 | UNSPECIFIED VISUAL LOSS | ||
| 3780 | ESOTROPIA | ||
| 36021 | PROGRESSIVE HIGH (DEGENERATIVE) MYOPIA | ||
| 36720 | ASTIGMATISM, UNSPECIFIED | ||
| 36731 | ANISOMETROPIA | ||
| 36781 | TRANSIENT REFRACTIVE CHANGE | ||
| 36800 | AMBLYOPIA, UNSPECIFIED | ||
| 36801 | STRABISMIC AMBLYOPIA | ||
| 36811 | SUDDEN VISUAL LOSS | ||
| 36812 | TRANSIENT VISUAL LOSS | ||
| 36840 | VISUAL FIELD DEFECT, UNSPECIFIED | ||
| 36900 | BLINDNESS OF BOTH EYES, IMPAIRMENT LEVEL NOT FURTHER SPECIFIED | ||
| 36960 | BLINDNESS, ONE EYE, NOT OTHERWISE SPECIFIED | ||
| 36970 | LOW VISION, ONE EYE, NOT OTHERWISE SPECIFIED | ||
| 37775 | CORTICAL BLINDNESS | ||
| 37800 | ESOTROPIA, UNSPECIFIED | ||
| 37801 | MONOCULAR ESOTROPIA | ||
| 37805 | ALTERNATING ESOTROPIA | ||
| 37810 | EXOTROPIA, UNSPECIFIED | ||
| 37815 | ALTERNATING EXOTROPIA | ||
| 37817 | ALTERNATING EXOTROPIA WITH V PATTERN | ||
| 37820 | INTERMITTENT HETEROTROPIA, UNSPECIFIED | ||
| 37821 | INTERMITTENT ESOTROPIA, MONOCULAR | ||
| 37824 | INTERMITTENT EXOTROPIA, ALTERNATING | ||
| 37830 | HETEROTROPIA, UNSPECIFIED | ||
| 37831 | HYPERTROPIA | ||
| 37832 | HYPOTROPIA | ||
| 37835 | ACCOMMODATIVE COMPONENT IN ESOTROPIA | ||
| 37881 | PALSY OF CONJUGATE GAZE | ||
| 37885 | ANOMALIES OF DIVERGENCE | ||
| Not otherwise specified | 3612 | SEROUS RETINAL DETACHMENT | |
| 3619 | UNSPECIFIED RETINAL DETACHMENT | ||
| 3633 | CHORIORETINAL SCARS | ||
| 3648 | OTHER DISORDERS OF IRIS AND CILIARY BODY | ||
| 3651 | OPEN-ANGLE GLAUCOMA | ||
| 3659 | UNSPECIFIED GLAUCOMA | ||
| 3669 | UNSPECIFIED CATARACT | ||
| 3769 | UNSPECIFIED DISORDER OF ORBIT | ||
| 3770 | PAPILLEDEMA | ||
| 3789 | UNSPECIFIED DISORDER OF EYE MOVEMENTS | ||
| 3798 | OTHER SPECIFIED DISORDERS OF EYE AND ADNEXA | ||
| 36020 | DEGENERATIVE DISORDER OF GLOBE, UNSPECIFIED | ||
| 36023 | SIDEROSIS OF GLOBE | ||
| 36030 | HYPOTONY OF EYE, UNSPECIFIED | ||
| 36033 | HYPOTONY ASSOCIATED WITH OTHER OCULAR DISORDERS | ||
| 36041 | BLIND HYPOTENSIVE EYE | ||
| 36043 | HEMOPHTHALMOS, EXCEPT CURRENT INJURY | ||
| 36044 | LEUCOCORIA | ||
| 36100 | RETINAL DETACHMENT WITH RETINAL DEFECT, UNSPECIFIED | ||
| 36103 | RECENT RETINAL DETACHMENT, PARTIAL, WITH GIANT TEAR | ||
| 36104 | RECENT RETINAL DETACHMENT, PARTIAL, WITH RETINAL DIALYSIS | ||
| 36105 | RECENT RETINAL DETACHMENT, TOTAL OR SUBTOTAL | ||
| 36107 | OLD RETINAL DETACHMENT, TOTAL OR SUBTOTAL | ||
| 36110 | RETINOSCHISIS, UNSPECIFIED | ||
| 36133 | MULTIPLE DEFECTS OF RETINA WITHOUT DETACHMENT | ||
| 36181 | TRACTION DETACHMENT OF RETINA | ||
| 36202 | PROLIFERATIVE DIABETIC RETINOPATHY | ||
| 36210 | BACKGROUND RETINOPATHY, UNSPECIFIED | ||
| 36211 | HYPERTENSIVE RETINOPATHY | ||
| 36216 | RETINAL NEOVASCULARIZATION NOS | ||
| 36229 | OTHER NONDIABETIC PROLIFERATIVE RETINOPATHY | ||
| 36231 | CENTRAL RETINAL ARTERY OCCLUSION | ||
| 36234 | TRANSIENT RETINAL ARTERIAL OCCLUSION | ||
| 36235 | CENTRAL RETINAL VEIN OCCLUSION | ||
| 36240 | RETINAL LAYER SEPARATION, UNSPECIFIED | ||
| 36250 | MACULAR DEGENERATION (SENILE) OF RETINA, UNSPECIFIED | ||
| 36254 | MACULAR CYST, HOLE, OR PSEUDOHOLE OF RETINA | ||
| 36256 | MACULAR PUCKERING OF RETINA | ||
| 36263 | LATTICE DEGENERATION OF RETINA | ||
| 36270 | HEREDITARY RETINAL DYSTROPHY, UNSPECIFIED | ||
| 36273 | VITREORETINAL DYSTROPHIES | ||
| 36274 | PIGMENTARY RETINAL DYSTROPHY | ||
| 36281 | RETINAL HEMORRHAGE | ||
| 36330 | CHORIORETINAL SCAR, UNSPECIFIED | ||
| 36332 | OTHER MACULAR SCARS OF RETINA | ||
| 36361 | CHOROIDAL HEMORRHAGE, UNSPECIFIED | ||
| 36370 | CHOROIDAL DETACHMENT, UNSPECIFIED | ||
| 36372 | HEMORRHAGIC CHOROIDAL DETACHMENT | ||
| 36405 | HYPOPYON | ||
| 36441 | HYPHEMA OF IRIS AND CILIARY BODY | ||
| 36470 | ADHESIONS OF IRIS, UNSPECIFIED | ||
| 36471 | POSTERIOR SYNECHIAE OF IRIS | ||
| 36472 | ANTERIOR SYNECHIAE OF IRIS | ||
| 36474 | ADHESIONS AND DISRUPTIONS OF PUPILLARY MEMBRANES | ||
| 36475 | PUPILLARY ABNORMALITIES | ||
| 36476 | IRIDODIALYSIS | ||
| 36477 | RECESSION OF CHAMBER ANGLE OF EYE | ||
| 36489 | OTHER DISORDERS OF IRIS AND CILIARY BODY | ||
| 36500 | PREGLAUCOMA, UNSPECIFIED | ||
| 36504 | OCULAR HYPERTENSION | ||
| 36514 | GLAUCOMA OF CHILDHOOD | ||
| 36520 | PRIMARY ANGLE-CLOSURE GLAUCOMA, UNSPECIFIED | ||
| 36560 | GLAUCOMA ASSOCIATED WITH UNSPECIFIED OCULAR DISORDER | ||
| 36600 | NONSENILE CATARACT, UNSPECIFIED | ||
| 36610 | SENILE CATARACT, UNSPECIFIED | ||
| 36612 | INCIPIENT SENILE CATARACT | ||
| 36616 | SENILE NUCLEAR SCLEROSIS | ||
| 36620 | TRAUMATIC CATARACT, UNSPECIFIED | ||
| 36630 | CATARACTA COMPLICATA, UNSPECIFIED | ||
| 36650 | AFTER-CATARACT, UNSPECIFIED | ||
| 36813 | VISUAL DISCOMFORT | ||
| 36815 | OTHER VISUAL DISTORTIONS AND ENTOPTIC PHENOMENA | ||
| 36816 | PSYCHOPHYSICAL VISUAL DISTURBANCES | ||
| 37000 | CORNEAL ULCER, UNSPECIFIED | ||
| 37003 | CENTRAL CORNEAL ULCER | ||
| 37004 | HYPOPYON ULCER | ||
| 37100 | CORNEAL OPACITY, UNSPECIFIED | ||
| 37105 | PHTHISICAL CORNEA | ||
| 37120 | CORNEAL EDEMA, UNSPECIFIED | ||
| 37123 | BULLOUS KERATOPATHY | ||
| 37140 | CORNEAL DEGENERATION, UNSPECIFIED | ||
| 37142 | RECURRENT EROSION OF CORNEA | ||
| 37143 | BAND-SHAPED KERATOPATHY | ||
| 37150 | HEREDITARY CORNEAL DYSTROPHY, UNSPECIFIED | ||
| 37157 | ENDOTHELIAL CORNEAL DYSTROPHY | ||
| 37158 | OTHER POSTERIOR CORNEAL DYSTROPHIES | ||
| 37160 | KERATOCONUS, UNSPECIFIED | ||
| 37162 | KERATOCONUS, ACUTE HYDROPS | ||
| 37170 | CORNEAL DEFORMITY, UNSPECIFIED | ||
| 37172 | DESCEMETOCELE | ||
| 37263 | SYMBLEPHARON | ||
| 37272 | CONJUNCTIVAL HEMORRHAGE | ||
| 37273 | CONJUNCTIVAL EDEMA | ||
| 37274 | VASCULAR ABNORMALITIES OF CONJUNCTIVA | ||
| 37275 | CONJUNCTIVAL CYSTS | ||
| 37289 | OTHER DISORDERS OF CONJUNCTIVA | ||
| 37420 | LAGOPHTHALMOS, UNSPECIFIED | ||
| 37430 | PTOSIS OF EYELID, UNSPECIFIED | ||
| 37451 | XANTHELASMA OF EYELID | ||
| 37482 | EDEMA OF EYELID | ||
| 37484 | CYSTS OF EYELIDS | ||
| 37489 | OTHER DISORDERS OF EYELID | ||
| 37515 | TEAR FILM INSUFFICIENCY, UNSPECIFIED | ||
| 37520 | EPIPHORA, UNSPECIFIED AS TO CAUSE | ||
| 37521 | EPIPHORA DUE TO EXCESS LACRIMATION | ||
| 37552 | STENOSIS OF LACRIMAL PUNCTUM | ||
| 37553 | STENOSIS OF LACRIMAL CANALICULI | ||
| 37554 | STENOSIS OF LACRIMAL SAC | ||
| 37555 | OBSTRUCTION OF NASOLACRIMAL DUCT, NEONATAL | ||
| 37556 | STENOSIS OF NASOLACRIMAL DUCT, ACQUIRED | ||
| 37561 | LACRIMAL FISTULA | ||
| 37630 | EXOPHTHALMOS, UNSPECIFIED | ||
| 37633 | ORBITAL EDEMA OR CONGESTION | ||
| 37641 | HYPERTELORISM OF ORBIT | ||
| 37646 | ENLARGEMENT OF ORBIT | ||
| 37651 | ENOPHTHALMOS DUE TO ATROPHY OF ORBITAL TISSUE | ||
| 37681 | ORBITAL CYSTS | ||
| 37689 | OTHER ORBITAL DISORDERS | ||
| 37700 | PAPILLEDEMA, UNSPECIFIED | ||
| 37703 | PAPILLEDEMA ASSOCIATED WITH RETINAL DISORDER | ||
| 37710 | OPTIC ATROPHY, UNSPECIFIED | ||
| 37721 | DRUSEN OF OPTIC DISC | ||
| 37724 | PSEUDOPAPILLEDEMA | ||
| 37741 | ISCHEMIC OPTIC NEUROPATHY | ||
| 37749 | OTHER DISORDERS OF OPTIC NERVE | ||
| 37852 | THIRD OR OCULOMOTOR NERVE PALSY, TOTAL | ||
| 37853 | FOURTH OR TROCHLEAR NERVE PALSY | ||
| 37854 | SIXTH OR ABDUCENS NERVE PALSY | ||
| 37855 | EXTERNAL OPHTHALMOPLEGIA | ||
| 37871 | DUANE’S SYNDROME | ||
| 37887 | OTHER DISSOCIATED DEVIATION OF EYE MOVEMENTS | ||
| 37923 | VITREOUS HEMORRHAGE | ||
| 37924 | OTHER VITREOUS OPACITIES | ||
| 37929 | OTHER DISORDERS OF VITREOUS | ||
| 37931 | APHAKIA | ||
| 37932 | SUBLUXATION OF LENS | ||
| 37933 | ANTERIOR DISLOCATION OF LENS | ||
| 37934 | POSTERIOR DISLOCATION OF LENS | ||
| 37941 | ANISOCORIA | ||
| 37942 | MIOSIS (PERSISTENT), NOT DUE TO MIOTICS | ||
| 37943 | MYDRIASIS (PERSISTENT), NOT DUE TO MYDRIATICS | ||
| 37950 | NYSTAGMUS, UNSPECIFIED | ||
| 37951 | CONGENITAL NYSTAGMUS | ||
| 37952 | LATENT NYSTAGMUS | ||
| 37954 | NYSTAGMUS ASSOCIATED WITH DISORDERS OF THE VESTIBULAR SYSTEM | ||
| 37955 | DISSOCIATED NYSTAGMUS | ||
| 37956 | OTHER FORMS OF NYSTAGMUS | ||
| 37959 | OTHER IRREGULARITIES OF EYE MOVEMENTS | ||
| 37991 | PAIN IN OR AROUND EYE | ||
| 37992 | SWELLING OR MASS OF EYE | ||
| 37993 | REDNESS OR DISCHARGE OF EYE | ||
| 37999 | OTHER ILL-DEFINED DISORDERS OF EYEa |
Author Contributions
Conceptualization, I.H. and E.S.; Formal analysis, E.S.; Methodology, E.T., C.B. and E.S.; Project administration, E.T.; Resources, E.T. and T.R.; Supervision, I.H.; Validation, E.T., N.F.R. and E.S.; Writing—original draft, I.H.; Writing—review & editing, I.H., S.L. and E.S. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of Soroka University Medical Center (protocol #0357-19-SOR, October 2019).
Informed Consent Statement
Patient consent was waived since the analysis was based on a deidentified computerized database.
Data Availability Statement
Unavailable according to the Helsinki protocol.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This research received no external funding.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Newman D.E., Paamoni-Keren O., Press F., Wiznitzer A., Mazor M., Sheiner E. Neonatal outcome in preterm deliveries between 23 and 27 weeks’ gestation with and without preterm premature rupture of membranes. Arch. Gynecol. Obstet. 2009;280:7–11. doi: 10.1007/s00404-008-0836-8. [DOI] [PubMed] [Google Scholar]
- 2.Vohr B. Long-term outcomes of moderately preterm, late preterm, and early term infants. Clin. Perinatol. 2013;40:739–751. doi: 10.1016/j.clp.2013.07.006. [DOI] [PubMed] [Google Scholar]
- 3.Gutvirtz G., Wainstock T., Sheiner E., Pariente G. Prematurity and Long-Term Respiratory Morbidity—What Is the Critical Gestational Age Threshold? J. Clin. Med. 2022;11:751. doi: 10.3390/jcm11030751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Davidesko S., Wainstock T., Sheiner E., Pariente G. Long-Term Infectious Morbidity of Premature Infants: Is There a Critical Threshold? J. Clin. Med. 2020;9:3008. doi: 10.3390/jcm9093008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zer S., Wainstock T., Sheiner E., Miodownik S., Pariente G. Identifying the Critical Threshold for Long-Term Pediatric Neurological Hospitalizations of the Offspring in Preterm Delivery. J. Clin. Med. 2021;10:2919. doi: 10.3390/jcm10132919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Torchin H., Morgan A.S., Ancel P.-Y. International comparisons of neurodevelopmental outcomes in infants born very preterm. Semin. Fetal. Neonatal Med. 2020;25:101109. doi: 10.1016/j.siny.2020.101109. [DOI] [PubMed] [Google Scholar]
- 7.Rogers E.E., Hintz S.R. Early neurodevelopmental outcomes of extremely preterm infants. Semin. Perinatol. 2016;40:497–509. doi: 10.1053/j.semperi.2016.09.002. [DOI] [PubMed] [Google Scholar]
- 8.O’Connor A.R., Wilson C.M., Fielder A.R. Ophthalmological problems associated with preterm birth. Eye. 2007;21:1254–1260. doi: 10.1038/sj.eye.6702838. [DOI] [PubMed] [Google Scholar]
- 9.Leung M.P., Thompson B., Black J., Dai S., Alsweiler J.M. The effects of preterm birth on visual development. Clin. Exp. Optom. 2018;101:4–12. doi: 10.1111/cxo.12578. [DOI] [PubMed] [Google Scholar]
- 10.Allen M.C., Cristofalo E.A., Kim C. Outcomes of Preterm Infants: Morbidity Replaces Mortality. Clin. Perinatol. 2011;38:441–454. doi: 10.1016/j.clp.2011.06.011. [DOI] [PubMed] [Google Scholar]
- 11.Preterm Birth. [(accessed on 16 November 2021)]. Available online: https://www.who.int/news-room/fact-sheets/detail/preterm-birth.
- 12.Ben-Shmuel A., Sheiner E., Tsumi E., Wainstock T., Feinblum D., Walfisch A. Early-term deliveries and long-term pediatric ophthalmic morbidity of the offspring. Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet. 2021:1–7. doi: 10.1002/ijgo.13875. [DOI] [PubMed] [Google Scholar]
- 13.Sheiner E., Hallak M., Twizer I., Mazor M., Katz M., Shoham-Vardi I. Lack of prenatal care in two different societies living in the same region and sharing the same medical facilities. J. Obstet. Gynaecol. J. Inst. Obstet. Gynaecol. 2001;21:453–458. doi: 10.1080/01443610120071974. [DOI] [PubMed] [Google Scholar]
- 14.Estis-Deaton A., Sheiner E., Wainstock T., Landau D., Walfisch A. The association between inadequate prenatal care and future healthcare use among offspring in the Bedouin population. Int. J. Gynaecol. Obstet. Off. Organ Int. Fed. Gynaecol. Obstet. 2017;139:284–289. doi: 10.1002/ijgo.12314. [DOI] [PubMed] [Google Scholar]
- 15.Abu-Ghanem S., Sheiner E., Sherf M., Wiznitzer A., Sergienko R., Shoham-Vardi I. Lack of prenatal care in a traditional community: Trends and perinatal outcomes. Arch. Gynecol. Obstet. 2012;285:1237–1242. doi: 10.1007/s00404-011-2153-x. [DOI] [PubMed] [Google Scholar]
- 16.Stephens A.S., Lain S.J., Roberts C.L., Bowen J.R., Nassar N. Survival, Hospitalization, and Acute-Care Costs of Very and Moderate Preterm Infants in the First 6 Years of Life: A Population-Based Study. J. Pediatr. 2016;169:61–68.e3. doi: 10.1016/j.jpeds.2015.10.028. [DOI] [PubMed] [Google Scholar]
- 17.Lui K., Vento M., Modi N., Kusuda S., Lehtonen L., Håkansson S., Rusconi F., Bassler D., Reichman B., Yang J., et al. Inter-center variability in neonatal outcomes of preterm infants: A longitudinal evaluation of 298 neonatal units in 11 countries. Semin. Fetal. Neonatal Med. 2021;26:101196. doi: 10.1016/j.siny.2021.101196. [DOI] [PubMed] [Google Scholar]
- 18.Kozeis N., Mavromichali M., Soubasi-Griva V., Agakidou E., Zafiriou D., Drossou V. Visual Function in Preterm Infants without Major Retinopathy of Prematurity or Neurological Complications. Am. J. Perinatol. 2012;29:747–754. doi: 10.1055/s-0032-1316446. [DOI] [PubMed] [Google Scholar]
- 19.Melville J.M., Moss T.J.M. The immune consequences of preterm birth. Front. Neurosci. 2013;7:79. doi: 10.3389/fnins.2013.00079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hagberg H., Mallard C., Jacobsson B. Role of cytokines in preterm labour and brain injury. BJOG Int. J. Obstet. Gynaecol. 2005;112((Suppl. S1)):16–18. doi: 10.1111/j.1471-0528.2005.00578.x. [DOI] [PubMed] [Google Scholar]
- 21.McAdams R.M., Juul S.E. The Role of Cytokines and Inflammatory Cells in Perinatal Brain Injury. Neurol. Res. Int. 2012;2012:1–15. doi: 10.1155/2012/561494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Rovet J., Simic N. The Role of Transient Hypothyroxinemia of Prematurity in Development of Visual Abilities. Semin. Perinatol. 2008;32:431–437. doi: 10.1053/j.semperi.2008.09.009. [DOI] [PubMed] [Google Scholar]
- 23.Darlow B.A., Hutchinson J.L., Henderson-Smart D.J., Donoghue D.A., Simpson J.M., Evans N.J., Australian and New Zealand Neonatal Network Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics. 2005;115:990–996. doi: 10.1542/peds.2004-1309. [DOI] [PubMed] [Google Scholar]
- 24.Haines L. UK population based study of severe retinopathy of prematurity: Screening, treatment, and outcome. Arch. Dis. Child. Fetal Neonatal Ed. 2005;90:F240–F244. doi: 10.1136/adc.2004.057570. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chiang M.F., Arons R.R., Flynn J.T., Starren J.B. Incidence of retinopathy of prematurity from 1996 to 2000: Analysis of a comprehensive New York state patient database. Ophthalmology. 2004;111:1317–1325. doi: 10.1016/j.ophtha.2003.10.030. [DOI] [PubMed] [Google Scholar]
- 26.Edy Siswanto J., Sauer P.J. Retinopathy of prematurity in Indonesia: Incidence and risk factors. J. Neonatal-Perinat. Med. 2017;10:85–90. doi: 10.3233/NPM-915142. [DOI] [PubMed] [Google Scholar]
- 27.Chiang M.-C., Tang J.-R., Yau K.-I.T., Yang C.-M. A proposal of screening guideline for retinopathy of prematurity in Taiwan. Acta Paediatr. Taiwanica Taiwan Er Ke Yi Xue Hui Za Zhi. 2002;43:204–207. [PubMed] [Google Scholar]
- 28.Ells A., Hicks M., Fielden M., Ingram A. Severe retinopathy of prematurity: Longitudinal observation of disease and screening implications. Eye. 2005;19:138–144. doi: 10.1038/sj.eye.6701437. [DOI] [PubMed] [Google Scholar]
- 29.Reynolds J.D. Evidence-Based Screening Criteria for Retinopathy of Prematurity: Natural History Data From the CRYO-ROP and LIGHT-ROP Studies. Arch. Ophthalmol. 2002;120:1470. doi: 10.1001/archopht.120.11.1470. [DOI] [PubMed] [Google Scholar]
- 30.Wright K., Anderson M.E., Walker E., Lorch V. Should Fewer Premature Infants Be Screened for Retinopathy of Prematurity in the Managed Care Era? Pediatrics. 1998;102:31–34. doi: 10.1542/peds.102.1.31. [DOI] [PubMed] [Google Scholar]
- 31.Todd D.A., Wright A., Smith J., NICUS Group Severe retinopathy of prematurity in infants <30 weeks’ gestation in New South Wales and the Australian Capital Territory from 1992 to 2002. Arch. Dis. Child. Fetal Neonatal Ed. 2007;92:F251–F254. doi: 10.1136/adc.2006.096479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Pohlandt F. Hypothesis: Myopia of prematurity is caused by postnatal bone mineral deficiency. Eur. J. Pediatr. 1994;153:234–236. doi: 10.1007/BF01954508. [DOI] [PubMed] [Google Scholar]
- 33.Holmström G., Rydberg A., Larsson E. Prevalence and development of strabismus in 10-year-old premature children: A population-based study. J. Pediatr. Ophthalmol. Strabismus. 2006;43:346–352. doi: 10.3928/01913913-20061101-04. [DOI] [PubMed] [Google Scholar]
- 34.Bremer D.L. Strabismus in Premature Infants in the First Year of Life. Arch. Ophthalmol. 1998;116:329. doi: 10.1001/archopht.116.3.329. [DOI] [PubMed] [Google Scholar]
- 35.Dogru M., Karakaya H., Baykara M., Özmen A., Koksal N., Goto E., Matsumoto Y., Kojima T., Shimazaki J., Tsubota K. Tear function and ocular surface findings in premature and term babies. Ophthalmology. 2004;111:901–905. doi: 10.1016/j.ophtha.2003.07.017. [DOI] [PubMed] [Google Scholar]
- 36.Gichuhi S., Bosire R., Mbori-Ngacha D., Gichuhi C., Wamalwa D., Maleche-Obimbo E., Farquhar C., Wariua G., Otieno P., John-Stewart G.C. Risk factors for neonatal conjunctivitis in babies of HIV-1 infected mothers. Ophthalmic Epidemiol. 2009;16:337–345. doi: 10.3109/09286580903144746. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Unavailable according to the Helsinki protocol.